Targeting neuronal nitric oxide synthase with gene transfer to modulate cardiac autonomic function

Arnolda, 2000, Nitric oxide limits pressure responses to sympathetic activation in rat spinal cord, Hypertension, 36, 1089, 10.1161/01.HYP.36.6.1089 Ashley, 2002, Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes, Circulation, 105, 3011, 10.1161/01.CIR.0000019516.31040.2D Baek, 1998, Gene therapy for restenosis, Circ. Res., 82, 295, 10.1161/01.RES.82.3.295 Baker, 1997, Prevention of vein graft failure, Cardiovasc. Res., 35, 442, 10.1016/S0008-6363(97)00116-8 Balligand, 1999, Regulation of cardiac beta-adrenergic response by nitric oxide, Cardiovasc. Res., 43, 607, 10.1016/S0008-6363(99)00163-7 Balligand, 1993, Control of cardiac muscle cell function by an endogenous nitric oxide signaling system, Proc. Natl. Acad. Sci. U.S.A, 90, 347, 10.1073/pnas.90.1.347 Bao, 1997, Transfection of a reporter plasmid into cultured cells by sonoporation in vitro, Ultrasound Med. Biol., 23, 953, 10.1016/S0301-5629(97)00025-2 Barouch, 2002, Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms, Nature, 416, 337, 10.1038/416337a Barry, 1996, Toward cell-targeting gene therapy vectors, Nat. Med., 2, 299, 10.1038/nm0396-299 Bates, 1996, Mitochondrial nitric oxide synthase, Biochem. Biophys. Res. Commun., 218, 40, 10.1006/bbrc.1996.0008 Biewenga, 1997, Plasmid-mediated gene transfer in neurons using the biolistics technique, J. Neurosci. Methods, 71, 67, 10.1016/S0165-0270(96)00127-6 Bueler, 1999, Adeno-associated viral vectors for gene transfer and gene therapy, Biol. Chem., 380, 613, 10.1515/BC.1999.078 Calupca, 2000, Origin of neuronal nitric oxide synthase (NOS)-immunoreactive fibers in guinea pig parasympathetic cardiac ganglia, J. Comp. Neurol., 426, 493, 10.1002/1096-9861(20001023)426:3<493::AID-CNE10>3.0.CO;2-P Casadei, 2000, Should we still use nitrovasodilators to test baroreflex sensitivity?, J. Hypertens., 18, 3, 10.1097/00004872-200018010-00002 Catala, 1995, A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene, Mol. Cell. Biol., 15, 4585, 10.1128/MCB.15.8.4585 Channon, 1996, Adenoviral gene transfer of nitric oxide synthase, Cardiovasc. Res., 32, 962, 10.1016/S0008-6363(96)00125-3 Choate, 1999, Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea-pig atria, J. Auton. Nerv. System, 75, 100, 10.1016/S0165-1838(98)00173-8 Choate, 2001, Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice, Am. J. Physiol. Heart Circ. Physiol., 281, H2310, 10.1152/ajpheart.2001.281.6.H2310 Chowdhary, 1999, Role of nitric oxide in the regulation of cardiovascular autonomic control, Clin. Sci., 97, 5, 10.1042/cs0970005 Chowdhary, 2002, Chronotropic effects of nitric oxide in the denervated human heart, J. Physiol., 541, 645, 10.1113/jphysiol.2001.015107 Coleman, 2003, Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo, Physiol. Genomics, 12, 221, 10.1152/physiolgenomics.00135.2002 Conlon, 1999, Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart, J. Auton. Nerv. System, 75, 136, 10.1016/S0165-1838(98)00185-4 Danialou, 2002, Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage, Mol. Ther., 6, 687, 10.1016/S1525-0016(02)90723-9 Danson, 2003, Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice, J. Physiol., 546, 225, 10.1113/jphysiol.2002.031781 DiFrancesco, 1991, Direct activation of cardiac pacemaker channels by intracellular cyclic AMP, Nature, 351, 145, 10.1038/351145a0 Dimmeler, 1999, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, 399, 601, 10.1038/21224 Doorbar, 1994, Isolation of a peptide antagonist to the thrombin receptor using phage display, J. Mol. Biol., 244, 361, 10.1006/jmbi.1994.1736 Dull, 1998, A third-generation lentivirus vector with a conditional packaging system, J. Virol., 72, 8463, 10.1128/JVI.72.11.8463-8471.1998 Einfeld, 2002, Advances towards targetable adenovirus vectors for gene therapy, Curr. Opin. Mol. Ther., 4, 444 Elvan, 1997, NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs, Am. J. Physiol., 272, H263 Farson, 2001, A new-generation stable inducible packaging cell line for lentiviral vectors, Hum. Gene Ther., 12, 981, 10.1089/104303401750195935 Ferdinandy, 2003, Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning, Br. J. Pharmacol., 138, 532, 10.1038/sj.bjp.0705080 Feron, 1996, Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells, J. Biol. Chem., 271, 22810, 10.1074/jbc.271.37.22810 Fisher, 2001, Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies, Gene Ther., 8, 341, 10.1038/sj.gt.3301389 Forstermann, 1994, Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions, Hypertension, 23, 1121, 10.1161/01.HYP.23.6.1121 French, 1994, Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis, Circulation, 90, 2402, 10.1161/01.CIR.90.5.2402 Friebe, 2003, Regulation of nitric oxide-sensitive guanylyl cyclase, Circ. Res., 93, 96, 10.1161/01.RES.0000082524.34487.31 Galione, 1993, cGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis [see comments], Nature, 365, 456, 10.1038/365456a0 Gehl, 2003, Electroporation, Acta Physiol. Scand., 177, 437, 10.1046/j.1365-201X.2003.01093.x Goins, 2002, Development of replication-defective herpes simplex virus vectors, Methods Mol. Med., 69, 481 Goldberg, 1977, Cyclic GMP metabolism and involvement in biological regulation, Annu. Rev. Biochem. 1997+ADs, 46, 823, 10.1146/annurev.bi.46.070177.004135 Goodson, 1994, High-affinity urokinase receptor antagonists identified with bacteriophage peptide display, Proc. Natl. Acad. Sci. USA, 91, 7129, 10.1073/pnas.91.15.7129 Griffith, 1984, The nature of endothelium-derived vascular relaxant factor, Nature, 308, 645, 10.1038/308645a0 Grossin, 2003, Direct gene transfer into rat articular cartilage by in vivo electroporation, FASEB J., 17, 829, 10.1096/fj.02-0518com Hakim, 1995, Evidence for a critical role of nitric oxide in the tonic excitation of rabbit renal sympathetic preganglionic neurons, J. Physiol., 482, 401, 10.1113/jphysiol.1995.sp020527 Han, 1994, An obligatory role for nitric oxide in autonomic control of mammalian heart rate, J. Physiol. (London), 476, 309, 10.1113/jphysiol.1994.sp020132 Han, 1996, Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells, Circ. Res., 78, 998, 10.1161/01.RES.78.6.998 Han, 1998, Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase, Proc. Natl. Acad. Sci. U.S.A, 95, 6510, 10.1073/pnas.95.11.6510 Heaton, D.A., Mohan, R.M., Krishnan, S.P., Everatt, L., Golding, S., Paterson, D.J., 2003. Cardiac nNOS gene transfer decreases beta-adrenergic hyper-responsiveness and enhances vagal function in spontaneously hypertensive rats. Circulation 108, S872. Henry, 1994, Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli, J. Virol., 68, 5239, 10.1128/JVI.68.8.5239-5246.1994 Herring, 2001, Nitric oxide–cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro, J. Physiol., 535, 507, 10.1111/j.1469-7793.2001.00507.x Herring, 2000, Pre-synaptic NO–cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria, J. Mol. Cell. Cardiol., 32, 1795, 10.1006/jmcc.2000.1214 Herring, 2002, Cholinergic control of heart rate by nitric oxide is site specific, News Physiol. Sci., 17, 202 Hevel, 1991, Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein, J. Biol. Chem., 266, 22789, 10.1016/S0021-9258(18)54421-5 Hong, 2003, Adenovirus stripping, Mol. Ther., 7, 692, 10.1016/S1525-0016(03)00067-4 Hwang, 2001, A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons, Hum. Gene Ther., 12, 1731, 10.1089/104303401750476230 Ignarro, 1991, Signal transduction mechanisms involving nitric oxide, Biochem. Pharmacol., 41, 485, 10.1016/0006-2952(91)90618-F Ignarro, 1987, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc. Natl. Acad. Sci. USA, 84, 9265, 10.1073/pnas.84.24.9265 Jiao, 1993, Particle bombardment-mediated gene transfer and expression in rat brain tissues, Biotechnology (N Y), 11, 497 Jumrussirikul, 1998, Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice, J. Clin. Invest., 102, 1279, 10.1172/JCI2843 Kanai, 2001, Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection, Proc. Natl. Acad. Sci. USA, 98, 14126, 10.1073/pnas.241380298 Kasparov, 1999, Differential effects of angiotensin II in the nucleus tractus solitarii of the rat—plausible neuronal mechanism, J. Physiol., 521, 227, 10.1111/j.1469-7793.1999.00227.x Kaye, 1995, Nitric oxide inhibits norepinephrine uptake in cardiac sympathetic neurons, Circulation, 92, 507 Keaney, 1996, Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation, Am. J. Physiol., 271, H2646 Kelly, 1996, Nitric oxide and cardiac function, Circ. Res., 79, 363, 10.1161/01.RES.79.3.363 Khan, 2003, Nitric oxide regulation of myocardial contractility and calcium cycling, Circ. Res., 92, 1322, 10.1161/01.RES.0000078171.52542.9E Kishi, 2001, Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release, Hypertension, 38, 896, 10.1161/hyp.38.4.896 Klimaschewski, 1992, Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart, Circ. Res., 71, 1533, 10.1161/01.RES.71.6.1533 Koga, 1999, Roles of nitric oxide in the spinal cord in cardiovascular regulation in rats, Neurosci. Lett., 267, 173, 10.1016/S0304-3940(99)00358-4 Krasnykh, 1998, Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob, J. Virol., 72, 1844, 10.1128/JVI.72.3.1844-1852.1998 Krasnykh, 2001, Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin, J. Virol., 75, 4176, 10.1128/JVI.75.9.4176-4183.2001 Krukoff, 1999, Central actions of nitric oxide in regulation of autonomic functions, Brain Res. Brain Res. Rev., 30, 52, 10.1016/S0165-0173(99)00010-7 Lampert, 2003, Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial, Am. J. Cardiol., 91, 137, 10.1016/S0002-9149(02)03098-9 Lemarchand, 1992, Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells, Proc. Natl. Acad. Sci. USA, 89, 6482, 10.1073/pnas.89.14.6482 Lemarchand, 1993, In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors, Circ. Res., 72, 1132, 10.1161/01.RES.72.5.1132 Li, 2002, Applications of muscle electroporation gene therapy, Curr. Gene Ther., 2, 101, 10.2174/1566523023348183 Lin, 1999, Nitric oxide signaling pathway mediates the L-arginine-induced cardiovascular effects in the nucleus tractus solitarii of rats, Life Sci., 65, 2439, 10.1016/S0024-3205(99)00510-X Lincoln, 1993, Intracellular cyclic GMP receptor proteins, FASEB J., 7, 328, 10.1096/fasebj.7.2.7680013 Lincoln, 1995, cGMP signalling through cAMP- and cGMP-dependent protein kinases, 305 Magnusson, 2001, Genetic retargeting of adenovirus, J. Virol., 75, 7280, 10.1128/JVI.75.16.7280-7289.2001 Manome, 2000, Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo, Hum. Gene Ther., 11, 1521, 10.1089/10430340050083252 Markos, 2002, Nitric oxide facilitates vagal control of heart rate via actions in the cardiac parasympathetic ganglia of the anaesthetised dog, Exp. Physiol., 87, 49, 10.1113/eph8702303 Mawe, 1996, Expression of choline acetyltransferase immunoreactivity in guinea pig cardiac ganglia, Cell Tissue Res., 285, 281, 10.1007/s004410050645 Michel, 1997, Nitric oxide synthases, J. Clin. Invest., 100, 2146, 10.1172/JCI119750 Mohan, 2000, Peripheral pre-synaptic pathway reduces the heart rate response to sympathetic activation following exercise training, Cardiovasc. Res., 47, 90, 10.1016/S0008-6363(00)00066-3 Mohan, 2002, Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function, Circ. Res., 91, 1089, 10.1161/01.RES.0000047531.75030.B5 Murad, 1994, Cyclic GMP, Adv. Pharmacol., 26, 1, 10.1016/S1054-3589(08)60047-2 Musialek, 1997, Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f), Circ. Res., 81, 60, 10.1161/01.RES.81.1.60 Naciff, 1999, Identification and transgenic analysis of a murine promoter that targets cholinergic neuron expression, J. Neurochem., 72, 17, 10.1046/j.1471-4159.1999.0720017.x Nakamura, 2003, Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber, J. Virol., 77, 2512, 10.1128/JVI.77.4.2512-2521.2003 Ng, 2001, Development of a FLP/frt system for generating helper-dependent adenoviral vectors, Mol. Ther., 3, 809, 10.1006/mthe.2001.0323 Nicklin, 2000, Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display, Circulation, 102, 231, 10.1161/01.CIR.102.2.231 Nicklin, 2001, Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus, Mol. Ther., 4, 534, 10.1006/mthe.2001.0489 Palmer, 1989, A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells, Biochem. Biophys. Res. Commun., 158, 348, 10.1016/S0006-291X(89)80219-0 Pasqualini, 1996, Organ targeting in vivo using phage display peptide libraries, Nature, 380, 364, 10.1038/380364a0 Paton, 2001, Unravelling mechanisms of action of angiotensin II on cardiorespiratory function using in vivo gene transfer, Acta Physiol. Scand., 173, 127, 10.1046/j.1365-201X.2001.00898.x Paton, 2001, Adenoviral vector demonstrates that angiotensin II-induced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat, J. Physiol., 531, 445, 10.1111/j.1469-7793.2001.0445i.x Paton, 2002, Nitric oxide and autonomic control of heart rate, Trends Neurosci., 25, 626, 10.1016/S0166-2236(02)02261-0 Pinsky, 1997, Mechanical transduction of nitric oxide synthesis in the beating heart, Circ. Res., 81, 372, 10.1161/01.RES.81.3.372 Rajotte, 1998, Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display, J. Clin. Invest., 102, 430, 10.1172/JCI3008 Reynolds, 2000, A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo, Mol. Ther., 2, 562, 10.1006/mthe.2000.0205 Ruggeri, 2000, Role of nitric oxide in the control of the heart rate within the nucleus ambiguus of rats, Neuroreport, 11, 481, 10.1097/00001756-200002280-00011 Sakai, 2000, Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo, Hypertension, 36, 1023, 10.1161/01.HYP.36.6.1023 Santis, 1999, Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR, J. Gen. Virol., 80, 1519, 10.1099/0022-1317-80-6-1519 Schmidt, 1993, The nitric oxide and cGMP signal transduction system, Biochim. Biophys. Acta, 1178, 153, 10.1016/0167-4889(93)90006-B Schulz, 1991, Nitric oxide synthase in cultured endocardial cells of the pig, Br. J. Pharmacol., 104, 21, 10.1111/j.1476-5381.1991.tb12378.x Schwarz, 1995, Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves, Circ. Res., 77, 841, 10.1161/01.RES.77.4.841 Sears, 1998, Effect of nitric oxide synthase inhibition on the sympatho-vagal control of heart rate, J. Auton. Nerv. System, 73, 63, 10.1016/S0165-1838(98)00123-4 Sears, 1999, NO–cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation, J. Appl. Physiol., 86, 510, 10.1152/jappl.1999.86.2.510 Sears, 2003, Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling, Circ. Res., 92, e52, 10.1161/01.RES.0000064585.95749.6D Sterin-Borda, 1998, Role of nitric oxide in cardiac beta-adrenoceptor-inotropic response, Cell Signal., 10, 253, 10.1016/S0898-6568(97)00125-3 Stuehr, 1992, Mammalian nitric oxide synthases, Adv. Enzymol. Relat. Areas Mol. Biol., 65, 287 Su, 2001, A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells, J. Vasc. Res., 38, 471, 10.1159/000051080 Takehara, 1995, Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide, Arch. Biochem. Biophys., 323, 27, 10.1006/abbi.1995.0005 Takita, 1998, Nitric oxide modulates sympathetic control of left ventricular contraction in vivo in the dog, J. Auton. Nerv. System, 71, 69, 10.1016/S0165-1838(98)00071-X Tanaka, 1995, Nitric oxide synthase containing nerves in the atrioventricular node of the guinea pig heart, J. Auton. Nerv. System, 51, 245, 10.1016/0165-1838(94)00137-9 Teichert, 2000, In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene, Am. J. Physiol. Heart Circ. Physiol., 278, H1352, 10.1152/ajpheart.2000.278.4.H1352 Tomko, 1997, HCAR and MCAR, PNAS, 94, 3352, 10.1073/pnas.94.7.3352 Trong, 1990, Amino acid sequence of the cyclic GMP stimulated cyclic nucleotide phosphodiesterase from bovine heart, Biochemistry, 29, 10280, 10.1021/bi00496a018 van Beusechem, 2000, Recombinant adenovirus vectors with knobless fibers for targeted gene transfer, Gene Ther., 7, 1940, 10.1038/sj.gt.3301323 Vandecasteele, 1999, Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase, Nat. Med., 5, 331, 10.1038/6553 Watkins, 1997, The ‘adenobody’ approach to viral targeting, Gene Ther., 4, 1004, 10.1038/sj.gt.3300511 Wells, 2000, Electroporation-enhanced gene delivery in mammary tumors, Gene Ther., 7, 541, 10.1038/sj.gt.3301141 White, 1992, Nitric oxide synthase is a cytochrome P-450 type hemoprotein, Biochemistry, 31, 6627, 10.1021/bi00144a001 Wu, 1995, Calcium-activated release of nitric oxide potentiates excitatory synaptic potentials in immature rat sympathetic preganglionic neurons, J. Neurophysiol., 74, 2600, 10.1152/jn.1995.74.6.2600 Wu, 1996, Potentiation of IPSCs by nitric oxide in immature rat sympathetic preganglionic neurons in vitro, J. Physiol., 495, 479, 10.1113/jphysiol.1996.sp021608 Xia, 1994, Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution, Structure, 2, 1259, 10.1016/S0969-2126(94)00126-X Xu, 1999, Nitric oxide synthase in cardiac sarcoplasmic reticulum, Proc. Natl. Acad. Sci. U.S.A, 96, 657, 10.1073/pnas.96.2.657 Zanzinger, 1999, Role of nitric oxide in the neural control of cardiovascular function, Cardiovasc. Res., 43, 639, 10.1016/S0008-6363(99)00085-1 Zhang, 2003, Human adenovirus serotypes 4 and 11 show higher binding affinity and infectivity for endothelial and carcinoma cell lines than serotype 5, J. Gen. Virol., 84, 687, 10.1099/vir.0.18666-0